Cargando…
Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition
INTRODUCTION: Tau pathology is associated with a number of age-related neurodegenerative disorders. Few treatments have been demonstrated to diminish the impact of tau pathology in mouse models and none are yet effective in humans. Histone deacetylase 6 (HDAC6) is an enzyme that removes acetyl group...
Autores principales: | Selenica, Maj-Linda, Benner, Leif, Housley, Steven B, Manchec, Barbara, Lee, Daniel C, Nash, Kevin R, Kalin, Jay, Bergman, Joel A, Kozikowski, Alan, Gordon, Marcia N, Morgan, Dave |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978441/ https://www.ncbi.nlm.nih.gov/pubmed/24576665 http://dx.doi.org/10.1186/alzrt241 |
Ejemplares similares
-
Epitope analysis following active immunization with tau proteins reveals immunogens implicated in tau pathogenesis
por: Selenica, Maj-Linda B, et al.
Publicado: (2014) -
LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice
por: Lee, Daniel C, et al.
Publicado: (2010) -
CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy
por: Joly-Amado, Aurelie, et al.
Publicado: (2020) -
Histone/protein deacetylase 11 targeting promotes Foxp3+ Treg function
por: Huang, Jianbing, et al.
Publicado: (2017) -
Tau deposition in young adults with drug‐resistant focal epilepsy
por: Smith, Kelsey M., et al.
Publicado: (2019)